Us Congress 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation (Page 4)

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB786

Introduced
1/28/25  
Preserving Patient Access to Accountable Care Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB741

Introduced
1/28/25  
Refer
1/28/25  
Stronger Engagement for Indian Health Needs Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB795

Introduced
1/28/25  
Pregnancy Is Not an Illness Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HR72

Introduced
1/28/25  
Expressing support for the designation of January 30, 2025, as CTE (chronic traumatic encephalopathy) and RHI (repeated head impacts) Awareness Day.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB746

Introduced
1/28/25  
Refer
1/28/25  
America First Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB772

Introduced
1/28/25  
Rural ER Access Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB859

Introduced
1/31/25  
Refer
1/31/25  
Report Pass
4/8/25  
Informing Consumers about Smart Devices Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB852

Introduced
1/31/25  
Expanded Food Safety Investigation Act of 2025This bill provides that the Food and Drug Administration (FDA) may, under specified circumstances, request access to a concentrated animal-feeding operation (i.e., a stabled or confined animal-feeding operation of a specified size) to conduct microbial sampling.Specifically, the bill allows the FDA to request access if the FDA determines that sampling is necessary to facilitate an investigation of a foodborne-illness outbreak, determine the cause of an outbreak, or address other public health needs. Concentrated animal-feeding operations must provide reasonable access for sampling, including sampling of plants, animals, water, and the environment. The bill imposes penalties on operations that refuse to provide reasonable access. Data collected in sampling efforts under this bill must be shared with the Department of Agriculture and state and federal public health agencies to facilitate the detection, investigation, and prevention of foodborne illness.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB830

Introduced
1/31/25  
SAFE Act Save Americans from the Fentanyl Emergency Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB870

Introduced
1/31/25  
Physicians for Underserved Areas Act This bill modifies how a hospital's residency positions are redistributed after it closes for purposes of graduate medical education payments under Medicare. Under current law, if a hospital with an approved medical residency program closes, the Centers for Medicare & Medicaid Services (CMS) must redistribute the hospital's residency positions to other hospitals in the following order: (1) hospitals in the same core-based statistical area as the closed hospital, (2) hospitals in the same state as the closed hospital, (3) hospitals in the same region of the country as the closed hospital, and (4) other remaining hospitals. In order to receive the additional positions, hospitals must demonstrate a likelihood of filling the positions within three years. The bill removes the requirement that the CMS prioritize hospitals in the same region of the country as the closed hospital. It also requires hospitals to demonstrate a likelihood of (1) starting to use the positions within two years, and (2) filling the positions within five years.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB866

Introduced
1/31/25  
Refer
1/31/25  
Report Pass
4/8/25  
ROUTERS Act Removing Our Unsecure Technologies to Ensure Reliability and Security Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB848

Introduced
1/31/25  
Voluntary Food Climate Labeling Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB903

Introduced
1/31/25  
Smoke and Heat Ready Communities Act of 2025This bill authorizes the Environmental Protection Agency (EPA) to make grants to air pollution control agencies to support the development and implementation of programs that support local communities in detecting, preparing for, communicating with the public about, or mitigating the environmental and public health aspects of wildfire smoke and extreme heat. The EPA must establish a formula to distribute the grants among air pollution control agencies.The bill requires the EPA to establish four Centers of Excellence for Wildfire Smoke and Extreme Heat at institutions of higher education to research (1) the effects of smoke emissions from wildland fires and extreme heat on public health, and (2) the means by which communities can better respond to impacts from such conditions.Additionally, the EPA must begin to carry out research tostudy the health effects of smoke emissions from wildland fires and extreme heat;develop and disseminate personal and community-based interventions to reduce exposure to, and health effects of, wildland fire smoke emissions and extreme heat;increase the quality of smoke and extreme heat monitoring and prediction tools and techniques; anddevelop implementation and communication strategies.The EPA must also establish a competitive grant program to assist certain entities (e.g., a state) in developing and implementing collaborative community plans for mitigating the impacts of smoke emissions from wildland fires and extreme heat.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB843

Introduced
1/31/25  
Prompt Approval of Safe Generic Drugs ActThis bill authorizes the Food and Drug Administration (FDA) to approve certain applications to market a generic drug despite the omission of certain safety information from the generic drug's labeling.Specifically, the FDA may not deem an abbreviated application for approval of a generic drug ineligible for approval solely because the drug's labeling omits safety information that is protected under another drug's patent or exclusivity protections. Similarly, a drug that is approved under this bill may not be considered mislabeled for lacking such safety information.Generally, an abbreviated application, for the purposes of this bill, is one that (1) uses required information from studies not conducted by the applicant; or (2) seeks approval of a drug that is, for drug approval purposes, a duplicate of an already-approved drug (i.e., a generic drug). Currently, the labeling for such a generic drug must generally be identical to that of the already-approved drug. This bill provides an exception to that requirement under the specified circumstances. For any drug approved under this bill, the FDA must require the drug's labeling to include any safety information that is necessary to assure safe use.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB893

Introduced
1/31/25  
Working Families Housing Tax Credit Act